Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 3 34Phase 1 20Phase 1/2 16Phase 2/3 5Phase NA 2Phase EARLY_PHASE1 2

Status

Completed 16Unknown 7Recruiting 3Not yet recruiting 3Withdrawn 2Terminated 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Myasthenia Gravis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Standard of Care 41Methods 37Practice Guidelines as Topic 36Exercise 36Educational Status 36Surveys and Questionnaires 33Early Intervention, Educational 32Radiotherapy 25Radiosurgery 24Magnetic Resonance Spectroscopy 23Interviews as Topic 20Blood Specimen Collection 17Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 12Counseling 12Radiation 11Palliative Care 11Nutrition Assessment 11Specimen Handling 9Resistance Training 9Proton Therapy 8Mammography 8Biopsy 8Yoga 7Radiofrequency Ablation 7Drug Therapy 7Diet Therapy 7Control Groups 7Referral and Consultation 6Radiation Dose Hypofractionation 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Rituximab × Clear all
NCT01829958 2026-05-06

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
201 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07071246 2025-07-17

Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis

Tang-Du Hospital

Phase NA Active not recruiting
30 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡